Quick Preview
✔️ Proliferative Diabetic Retinopathy with Ischemic Neuropathy
71M
Severe diabetic background, OD completely blind
OS: visual field expanded >2.5× after ~10 sessions
Proliferative Diabetic Retinopathy with Ischemic Neuropathy
(Click to Expand)
Quick Facts
- Patient: 71-year-old male
- Condition: Proliferative diabetic retinopathy with ischemic optic neuropathy in OS
- Context: Advanced diabetes, heart disease, and history of multiple retinal laser surgeries. OD completely blind (no light perception). OS with 20/80 near vision, contrast sensitivity 0.64 (normal 1.68), and severely restricted visual field.
- Protocol: 10 coMra Delta 905 Eye Protocol treatments (daily, some days twice) plus brief syntonic phototherapy.
- Outcome Highlights: No change in acuity or contrast sensitivity, but horizontal field increased from 15° to 25°, vertical from 10° to 25°, more than doubling total visual field area (~2.5×). Patient reported markedly improved ability to take in surroundings.
📂 Expand Full Case Details
Case Details
This out-of-town patient presented in poor systemic health, with vision in his only seeing eye (OS) severely impaired both in clarity and field.
Pre-treatment testing confirmed:
- Acuity: ~20/80 near vision
- Contrast sensitivity: 0.64 (normal 1.68)
- Visual field: Horizontal max 15°, vertical 10°
Treatment consisted of 10 in-office coMra sessions over two weeks, some days twice daily, using the Eye Protocol. A short course of syntonic phototherapy was also provided.
Results:
Post-treatment field measurements showed horizontal expansion to 25° and vertical to 25°, representing more than a doubling of usable visual field area (~2.5× increase). While chart-based measures (acuity and contrast sensitivity) did not change, the patient noticed a substantial improvement in functional vision, describing it as “definitely got more space to see.”
This expansion allowed him to take in more of his environment despite unchanged sharpness, a change considered significant for daily living and mobility.
Related science:
-
Transcranial laser + magnetic therapy and trabecular-targeted laser-magnet stimulation improved fields and ocular blood flow (n=165 eyes, Egorov 2013; n=96 treated vs 94 control eyes, Sidelnikova 2014), paralleling the 2.5× field expansion here.
-
Bio-regulated ultrasound outperformed standard ultrasound on outflow and optic-nerve function (n=157 treated vs 49 control eyes, Novikova 2011), supporting functional gains even when acuity plateaus.
✅ Next Steps for Clinicians
📂 Expand For Details
📅 Book a Call
Explore how coMra could fit into your care model Schedule a Conversation →
📄 Download Clinical Brief
Access protocols and objective outcomes
Get the Brief →
💬 Ask a Clinical Question
Get direct answers from our clinical team
Submit Your Question →📨
👉 Return to Eye Main Page